Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study | |
Wang, Yi-Jun[1]; Zhang, Yun-Kai[1]; Zhang, Guan-Nan[1]; Al Rihani, Sweilem B.[2]; Wei, Meng-Ning[3,4]; Gupta, Pranav[1]; Zhang, Xiao-Yu[1]; Shukla, Suneet[6]; Ambudkar, Suresh V.[6]; Kaddoumi, Amal | |
2017 | |
卷号 | 396期号:[db:dc_citation_issue]页码:145 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3346384 |
专题 | 暨南大学 |
作者单位 | 1.[1]St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA 2.[2]Univ Louisiana Monroe, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71201 USA 3.[3]Jinan Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Genet Med, Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China 4.[4]Jinan Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Genet Med, Inst Biomed,Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Guangdong, Peoples R China 5.[5]Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China 6.[6]NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA |
推荐引用方式 GB/T 7714 | Wang, Yi-Jun[1],Zhang, Yun-Kai[1],Zhang, Guan-Nan[1],et al. Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study[J],2017,396([db:dc_citation_issue]):145. |
APA | Wang, Yi-Jun[1].,Zhang, Yun-Kai[1].,Zhang, Guan-Nan[1].,Al Rihani, Sweilem B.[2].,Wei, Meng-Ning[3,4].,...&Chen, Zhe-Sheng[1,5].(2017).Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.,396([db:dc_citation_issue]),145. |
MLA | Wang, Yi-Jun[1],et al."Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study".396.[db:dc_citation_issue](2017):145. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论